Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $107

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and lowers the price target from $109 to $107.